
Company valuation, historical trends, and peer comparisons.
According to Annovis Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 31.82M. This represents a change of -33.25% compared to the average of 47.68M of the last 4 quarters.
The mean historical Enterprise Value of Annovis Bio, Inc. over the last ten years is 74.55M. The current 31.82M Enterprise Value has changed -57.31% with respect to the historical average. Over the past ten years (40 quarters), ANVS's Enterprise Value was at its highest in in the June 2021 quarter at 581.21M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
74.55M
Median
65.35M
Minimum
39.49M
Maximum
162.98M
Discovering the peaks and valleys of Annovis Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 123.79%
Maximum Annual Enterprise Value = 162.98M
Minimum Annual Increase = -68.88%
Minimum Annual Enterprise Value = 39.49M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 51.58M | 1.68% |
| 2024 | 50.73M | -68.88% |
| 2023 | 162.98M | 100.61% |
| 2022 | 81.24M | -8.08% |
| 2021 | 88.38M | 123.79% |
| 2020 | 39.49M | -40.29% |
| 2019 | 66.15M | 1.22% |
| 2018 | 65.35M | 0.48% |
The current Enterprise Value of Annovis Bio, Inc. (ANVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
88.43M
5-year avg
86.98M
10-year avg
74.55M
Annovis Bio, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (-19745862663743.00), less than PolyPid Ltd. (103.88M), less than Celularity Inc. (62.06M), greater than BioAtla, Inc. (7.20M), greater than Evaxion Biotech A/S (12.12M), greater than Actinium Pharmaceuticals, Inc. (11.56M), less than PDS Biotechnology Corporation (78.30M), less than BioXcel Therapeutics, Inc. (0), greater than Elutia Inc (28.87M), less than MAIA Biotechnology, Inc. (42.17M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -19745862663743.00 | $4.34M | |
| 103.88M | $108.87M | |
| 62.06M | $26.63M | |
| 7.20M | $2.88M | |
| 12.12M | $19.01M | |
| 11.56M | $46.69M | |
| 78.30M | $79.54M | |
| 0 | $2.28M | |
| 28.87M | $37.97M | |
| 42.17M | $69.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annovis Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Annovis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Annovis Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Annovis Bio, Inc. (ANVS)?
What is the 3-year average Enterprise Value for Annovis Bio, Inc. (ANVS)?
What is the 5-year average Enterprise Value for Annovis Bio, Inc. (ANVS)?
How does the current Enterprise Value for Annovis Bio, Inc. (ANVS) compare to its historical average?